hold

(Reuters) - Goldman Sachs has appealed to the U.S. Federal Reserve over its results in the latest "stress test" by the Fed that is set to force the bank to hold more capital, the Financial Times reported on Sunday, citing people familiar…

By David Shepardson WASHINGTON (Reuters) - A U.S. appeals court said on Friday it has temporarily halted the Federal Communications Commission's reinstatement of landmark net neutrality rules until Aug. 5 while it considers legal…

The Reserve Bank of New Zealand left interest rates unchanged at 5.50% for the eighth straight month in July, as expected. Their official statement indicated that their restrictive monetary policy had succeeded in reducing price…

By Colleen Howe and Trixie Yap (Reuters) - Oil prices were little changed on Tuesday after a hurricane that hit a major U.S. oil production hub in Texas caused less damage than markets had expected, easing concerns about supply…

The Reserve Bank of New Zealand will announce its decision at 2pm NZ time on Wednesday 10 July, which is0200 GMT on the 10th and 2200 EST on the 9th.Brief comments via Westpac on what to expect:We do not expect any change to the policy rate…

Investing.com - At the start of each quarter, Deutsche Bank presents its top investment ideas for each sector over the next 12 months. It's time to shine a light on the healthcare sector. The first healthcare sector player Deutsche Bank is…

Written by Saroopia Ganguly BANGALORE (Reuters) - The euro is expected to weaken modestly against the U.S. dollar this month before rallying by the end of the year, currency strategists polled by Reuters said, even though financial markets…

Judges And returned the cases to the lower courts. In challenges from corporate trade associations. While the details vary, both laws are intended to address conservative complaints that social media companies were liberal-leaning…

Ethereum fans have been heading into a Fourth of July fireworks celebration of a different kind: the launch of the first Ethereum spot trading fund. Related reading Investor enthusiasm waned when the U.S. Securities and…

On Friday, HC Wainwright maintained a Buy rating on shares of Lava Therapeutics NV (NASDAQ: LVTX), with a $6.00 price target. Lava Therapeutics, a biotechnology company, recently participated in the 2nd Annual Immune Cell Engager…